Q/C Technologies, Inc. (QCLS) stock
QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.33+0.01 (+4.05%)
Close on Nov 17, 2026Market cap $2.74MP/E –Yield –
Q/C Technologies operating margin
Operating margin is operating income as a percentage of revenue.
Q/C Technologies's operating margin for the twelve months ending Jun 30, 2020 was -716.8%. For fiscal 2019 it was -220.2%, against -604.0% the year before. The highest annual figure on record is -50.6% in fiscal 2013.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | -220.2% | +383.9 |
| FY2018 | Dec 31, 2018 | -604.0% | −406.9 |
| FY2017 | Dec 31, 2017 | -197.1% | −84.7 |
| FY2016 | Dec 31, 2016 | -112.4% | +345.4 |
| FY2015 | Dec 31, 2015 | -457.8% | −385.4 |
| FY2014 | Dec 31, 2014 | -72.4% | −21.8 |
| FY2013 | Dec 31, 2013 | -50.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2020 | Mar 31, 2020 | -975.1% | −821.5 |
| Q4 FY2019 | Dec 31, 2019 | -867.8% | +180.6 |
| Q3 FY2019 | Sep 30, 2019 | -201.8% | +359.0 |
| Q2 FY2019 | Jun 30, 2019 | -176.9% | +224.4 |
| Q1 FY2019 | Mar 31, 2019 | -153.6% | +472.4 |
| Q4 FY2018 | Dec 31, 2018 | -1048.5% | −972.0 |
| Q3 FY2018 | Sep 30, 2018 | -560.8% | −356.7 |
| Q2 FY2018 | Jun 30, 2018 | -401.3% | −233.2 |
| Q1 FY2018 | Mar 31, 2018 | -626.0% | −675.1 |
| Q2 FY2017 | Jun 30, 2017 | -76.5% | +29.6 |
| Q1 FY2017 | Mar 31, 2017 | -204.1% | +1.4 |
| Q4 FY2016 | Dec 31, 2016 | -168.1% | – |
| Q3 FY2016 | Sep 30, 2016 | 49.1% | – |
| Q2 FY2016 | Jun 30, 2016 | -106.1% | – |
| Q1 FY2016 | Mar 31, 2016 | -205.5% | – |
See a number that looks wrong?